Featured Quality Research

The American Heart Association's (AHA) Get With The Guidelines® (GWTG) is a hospital-based quality improvement program designed to close the treatment gap in cardiovascular disease, heart failure, resuscitation and stroke. Our suite of quality improvement programs collects millions of patient records that allow investigator-led research using this data. The AHA greatly values clinical investigators and their research.

Each month we will spotlight the author of the newest Quality Improvement Research coming from the Get With The Guidelines Data Registries.  

Questions with the Experts

October 2020:

Feras Akbik, MD, PhD
Assistant Professor, Neurology and Neurosurgery
Emory University School of Medicine

Data Registry: Get With The Guidelines®-Stroke

Published Study: Trends in Reperfusion Therapy for In-Hospital Ischemic Stroke in the Endovascular Therapy Era; JAMA Neurology(link opens in new window)

When you started this study, what were you aiming to learn? 
"As a resident physician, I often found that inpatient stroke alerts were a frustrating mixture of confusion and delay, while strokes in the emergency department were routine. I wanted to better understand whether this was a more widespread experience, and if so, what the impact of these delays were on patient outcomes.  The hope was to identify tractable targets to guide efforts to improve stroke therapy for patients already under our care in the hospital".

Who was your target patient population and how did you study them? 
"Leveraging the national Get With The Guidelines-Stroke registry, we found that the in-hospital onset strokes are increasingly reported from 2008-2018.  Our target population was patients who received reperfusion therapy, either with mechanical thrombectomy and or intravenous thrombolysis.  We dichotomized these patients by site of stroke onset, either in or out of the hospital, and then compared quality metrics as well as functional outcomes."

Did the study results turn out as you had expected or were you surprised with what you found? 
"We predicted that the use of intravenous thrombolytics would be fairly constant throughout the study period, while endovascular therapy would significantly increase in 2015 (after publication of the pivotal clinical trials).  We did see a significant increase in endovascular therapy starting in 2015, but we were surprised to see a steady, year-over-year increase in intravenous thrombolysis, more than doubling over the 10-year period."

How do you see this study impacting the future of medicine and patient care? 
"Hospitals that have acknowledged the importance and morbidity of inpatient strokes have developed and practiced inpatient stroke protocols, minimizing the disparities in treatment and outcomes after in-hospital onset strokes.  We hope that by highlighting the persistence of these disparities nationwide helps our colleagues around the country revisit their inpatient stroke protocols.  If they do not have one, this is a call to develop and implement one.  If they do have one, our data highlight the importance of reevaluating and practicing the protocol to maximize patient outcomes.  Triage will always be faster in the emergency department; it's what they do all day, every day.  But we can do better upstairs." 


September 2020:

Madeline Sterling, MD, MPH, MS
Associate Professor of Medicine
Weill Cornell Medicine, New York, NY

Data Registry: Get With The Guidelines®-Heart Failure

Published Study: Home Health Care Use and Post-Discharge Outcomes After Heart Failure Hospitalizations JACC: Heart Failure

When you started this study, what were you aiming to learn? 
"There have been a few studies to suggest that home health care (HHC) use has been increasing among older adults discharged home after a heart failure (HF) hospitalization, but few contemporary studies have investigated this at the national level. HHC provides patients with home-based personal and skilled medical care after discharge, so our team wanted to understand how these services were being used and how they influenced post-discharge outcomes among HF patients. In that context, we had two main objectives. First, we aimed to describe utilization patterns of HHC among Medicare beneficiaries after a HF hospitalization. Second, we aimed to examine associations among HHC and post-discharge outcomes, including short-term readmission and mortality.

Who was your target patient population and how did you study them? 
"We studied Medicare beneficiaries hospitalized at American Heart Association’s Get With The Guidelines-HF (GWTG-HF) centers between 2005 and 2015 with a primary discharge diagnosis of HF, who had Medicare-linked data available, and were discharged home alive. Propensity score matching and Cox proportional hazards models were used to evaluate the associations between HHC and post-discharge outcomes."

Did the study results turn out as you had expected or were you surprised with what you found? 
"We found that more than one third of Medicare beneficiaries hospitalized for HF in the US were discharged home with HHC; this is equivalent to an absolute increase of 5% from 2005 to 2015. HHC recipients were older, more likely to be female, and had more comorbidities than those who did not receive HHC after discharge. We found that HHC recipients had a higher risk of 30 and 90-day all-cause and HF-specific readmission and a higher risk of all-cause mortality than those who did not receive HHC. This surprised us, as we hypothesized that HHC would be associated with a decrease in the risk of these outcomes. However, we urge readers to interpret the results cautiously, as the allocation of HHC was not random, and unmeasured confounding may have persisted. That is, while we adjusted for many covariates in our analyses, we were unable to account for some important ones (such as patients’ functional needs and cognition, HF severity, and social support) which may affect HHC and post-discharge outcomes.

How do you see this study impacting the future of medicine and patient care? 
"Health care providers and health systems should be aware of the increasing utilization of HHC among older adults discharged home after a HF hospitalization in the US. Further research is needed to determine the intensity and type of services patients received with their HHC, something we were unable to do in this study, but which may impact outcomes. Additionally, research is needed to understand the appropriateness and preventability of readmissions among patients with HF sick enough to receive HHC after discharge." 


August 2020:

Saket Girotra, MD, SM
Associate Professor of Medicine
University of Iowa Carver College of Medicine

Data Registry: Get With The Guidelines®- Resuscitation

Published Study: Association of Hospital-Level Acute Resuscitation and Post resuscitation Survival With Overall Risk-Standardized Survival to Discharge for In-Hospital Cardiac Arrest JAMA Network Open

When you started this study, what were you aiming to learn? 
"Prior work from GWTG-Resuscitation has shown that survival for survival for in-hospital cardiac arrest (IHCA) varies by more than 3-fold. We wanted to find out whether high survival at top-performing hospitals is because they excel in running codes, excel in post-resuscitation care, or both.

Who was your target patient population and how did you study them? 
"We used data from 290 hospitals participating in GWTG-R during 2015-2018. For each hospital in our study, we calculated risk-adjusted rates of acute resuscitation survival, defined as return of spontaneous circulation (ROSC) for at least 20 minutes, post-resuscitation survival, defined as survival to discharge, in patients who achieved ROSC and overall survival using a validated methodology. We examined the extent to which hospital rates of overall survival were correlated with rates of acute resuscitation and post-resuscitation survival."

Did the study results turn out as you had expected or were you surprised with what you found? 
"We found that a hospital’s overall risk-standardized survival rate (RSSR) was correlated with both acute resuscitation and post-resuscitation survival which was expected because in order for patients to survive, they must achieve ROSC and survive during the post-resuscitation phase. However, the strength of the correlation between overall RSSR and post-resuscitation survival was much stronger compared to its correlation with acute resuscitation survival (rho=0.90 vs. 0.50). Additionally, we found no correlation between acute resuscitation and post-resuscitation survival. This finding was rather unexpected and suggested that hospitals that excel in IHCA survival, either excel in acute resuscitation, or post-resuscitation survival but not consistently both phases.

How do you see this study impacting the future of medicine and patient care? 
"Our findings have important implications for quality improvement for resuscitation care. The current AHA GWTG-R quality measures that incentivize hospitals are focused only on acute resuscitation. Our findings suggest that in order for us to achieve continued improved in overall IHCA survival, there is an urgent need to identify best practices for post-resuscitation survival."